These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25015634)

  • 1. Development and validation of a tetra-primer amplification refractory mutation system-polymerase chain reaction combined with melting analysis-assay for clinical JAK2 V617F mutation detection.
    Liu W; Hu T; Chen Y; Zhang X; Gu X; Guan M
    Mol Diagn Ther; 2014 Oct; 18(5):579-85. PubMed ID: 25015634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melting point assay for the JAK2 V617F mutation, comparison with amplification refractory mutation system (ARMS) in diagnostic samples, and implications for daily routine.
    Ochsenreither S; Reinwald M; Thiel E; Burmeister T
    Mol Diagn Ther; 2010 Jun; 14(3):185-90. PubMed ID: 20560681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the JAK2(V617F) mutation in myeloproliferative disorders by melting curve analysis using the LightCycler system.
    Olsen RJ; Tang Z; Farkas DH; Bernard DW; Zu Y; Chang CC
    Arch Pathol Lab Med; 2006 Jul; 130(7):997-1003. PubMed ID: 16831057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multiplex snapback primer system for the enrichment and detection of JAK2 V617F and MPL W515L/K mutations in Philadelphia-negative myeloproliferative neoplasms.
    Wu Z; Zhang Y; Zhang X; Xu X; Kang Z; Li S; Zhang C; Su B; Guan M
    Biomed Res Int; 2014; 2014():458457. PubMed ID: 24729973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating the Sensitivity of High-Resolution Melting Analysis for JAK2 V617F Mutation in the Clinical Setting.
    Lin CY; Ho CM; Tamamyan G; Yang SF; Peng CT; Chang JG
    J Clin Lab Anal; 2016 Nov; 30(6):838-844. PubMed ID: 27169616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.
    Ho CL; Wu YY; Hung HM; Chang PY; Kao WY; Chen YC; Chao TY
    J Formos Med Assoc; 2012 Jan; 111(1):34-40. PubMed ID: 22333011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tetra-primer polymerase chain reaction approach for the detection of JAK2 V617F mutation.
    Koksal V; Etlik O; Arican-Baris ST; Baris I
    Genet Test; 2007; 11(4):463-6. PubMed ID: 18294066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and inter-laboratory validation of unlabeled probe melting curve analysis for detection of JAK2 V617F mutation in polycythemia vera.
    Wu Z; Yuan H; Zhang X; Liu W; Xu J; Zhang W; Guan M
    PLoS One; 2011; 6(10):e26534. PubMed ID: 22028900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods.
    Cankovic M; Whiteley L; Hawley RC; Zarbo RJ; Chitale D
    Am J Clin Pathol; 2009 Nov; 132(5):713-21. PubMed ID: 19846812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of a Low-Cost, Sensitive PNA Clamping PCR Method for JAK2 V617F Variant Detection.
    Di Francia R; Crisci S; Muto T; Giancola C; Petriccone L; Catapano O; Cummarro A; Pinto A; Frigeri F
    J Appl Lab Med; 2020 Jul; 5(4):643-655. PubMed ID: 32407536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR.
    Waterhouse M; Follo M; Pfeifer D; von Bubnoff N; Duyster J; Bertz H; Finke J
    Ann Hematol; 2016 Apr; 95(5):739-44. PubMed ID: 26931113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR.
    Kinz E; Leiherer A; Lang AH; Drexel H; Muendlein A
    Int J Lab Hematol; 2015 Apr; 37(2):217-24. PubMed ID: 24963593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of acquired Janus kinase 2 V617F mutation in myeloproliferative disorders by fluorescence melting curve analysis.
    Reading NS; Lim MS; Elenitoba-Johnson KS
    Mol Diagn Ther; 2006; 10(5):311-7. PubMed ID: 17022694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders.
    Chen Q; Lu P; Jones AV; Cross NC; Silver RT; Wang YL
    J Mol Diagn; 2007 Apr; 9(2):272-6. PubMed ID: 17384221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis.
    Murugesan G; Aboudola S; Szpurka H; Verbic MA; Maciejewski JP; Tubbs RR; Hsi ED
    Am J Clin Pathol; 2006 Apr; 125(4):625-33. PubMed ID: 16627272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis.
    Cao HC; Lin J; Qian J; Yao DM; Li Y; Yang J; Chen Q; Chai HY; Xiao GF
    J Clin Lab Anal; 2011; 25(4):300-4. PubMed ID: 21786333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms.
    Lee E; Lee KJ; Park H; Chung JY; Lee MN; Chang MH; Yoo J; Lee H; Kong SY; Eom HS
    Ann Lab Med; 2018 Mar; 38(2):147-154. PubMed ID: 29214759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.
    Tan AY; Westerman DA; Dobrovic A
    Am J Clin Pathol; 2007 Jun; 127(6):977-81. PubMed ID: 17509995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of JAK2 V617F mutation using high-resolution melting analysis with LightScanner platform.
    Qian J; Lin J; Yao DM; Chen Q; Xiao GF; Ji RB; Li Y; Yang J; Qian Z
    Clin Chim Acta; 2010 Dec; 411(23-24):2097-100. PubMed ID: 20728437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative assay for JAK2(V617F) mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis.
    Vannucchi AM; Pancrazzi A; Bogani C; Antonioli E; Guglielmelli P
    Leukemia; 2006 Jun; 20(6):1055-60. PubMed ID: 16572198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.